» Articles » PMID: 30518135

Vitamin E Metabolic Effects and Genetic Variants: A Challenge for Precision Nutrition in Obesity and Associated Disturbances

Overview
Journal Nutrients
Date 2018 Dec 7
PMID 30518135
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

Vitamin E (VE) has a recognized leading role as a contributor to the protection of cell constituents from oxidative damage. However, evidence suggests that the health benefits of VE go far beyond that of an antioxidant acting in lipophilic environments. In humans, VE is channeled toward pathways dealing with lipoproteins and cholesterol, underlining its relevance in lipid handling and metabolism. In this context, both VE intake and status may be relevant in physiopathological conditions associated with disturbances in lipid metabolism or concomitant with oxidative stress, such as obesity. However, dietary reference values for VE in obese populations have not yet been defined, and VE supplementation trials show contradictory results. Therefore, a better understanding of the role of genetic variants in genes involved in VE metabolism may be crucial to exert dietary recommendations with a higher degree of precision. In particular, genetic variability should be taken into account in targets concerning VE bioavailability per se or concomitant with impaired lipoprotein transport. Genetic variants associated with impaired VE liver balance, and the handling/resolution of oxidative stress might also be relevant, but the core information that exists at present is insufficient to deliver precise recommendations.

Citing Articles

Nutritional Status of Vitamin E and Its Association with Metabolic Health in Adults.

Szewczyk K, Brys J, Brzezinska R, Gornicka M Nutrients. 2025; 17(3).

PMID: 39940266 PMC: 11821082. DOI: 10.3390/nu17030408.


Impact of Genetic Variants on Vitamin E Levels in an Italian Cohort of Bariatric Surgery Patients: A Focus on SNPs Involved with Transport and Bioavailability.

Ricci C, Bufano A, Iraci Sareri G, Simon Batzibal M, Marzocchi C, Simoncelli G Int J Mol Sci. 2025; 26(2.

PMID: 39859364 PMC: 11765794. DOI: 10.3390/ijms26020651.


Enhancing health and therapeutic potential: innovations in the medicinal and pharmaceutical properties of soy bioactive compounds.

Rahman U, Younas Z, Ahmad I, Yousaf T, Latif R, Rubab U Front Pharmacol. 2024; 15:1397872.

PMID: 39421675 PMC: 11483366. DOI: 10.3389/fphar.2024.1397872.


The use of vitamin E in ocular health: Bridging omics approaches with Tocopherol and Tocotrienol in the management of glaucoma.

Latib F, Zafendi M, Lazaldin M Food Chem (Oxf). 2024; 9:100224.

PMID: 39415777 PMC: 11481750. DOI: 10.1016/j.fochms.2024.100224.


Genetic Factors Contributing to Interindividual Variability of α-Tocopherol Levels in Subcutaneous Adipose Tissue among Healthy Adult Males.

Zumaraga M, Borel P, Gleize B, Nowicki M, Ould-Ali D, Landrier J Nutrients. 2024; 16(15).

PMID: 39125437 PMC: 11314220. DOI: 10.3390/nu16152556.


References
1.
Brigelius-Flohe R, Traber M . Vitamin E: function and metabolism. FASEB J. 1999; 13(10):1145-55. View

2.
Brooks-Wilson A, Marcil M, Clee S, Zhang L, Roomp K, Van Dam M . Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat Genet. 1999; 22(4):336-45. DOI: 10.1038/11905. View

3.
Rust S, ROSIER M, Funke H, Real J, Amoura Z, Piette J . Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1. Nat Genet. 1999; 22(4):352-5. DOI: 10.1038/11921. View

4.
Orso E, Broccardo C, Kaminski W, Bottcher A, Liebisch G, Drobnik W . Transport of lipids from golgi to plasma membrane is defective in tangier disease patients and Abc1-deficient mice. Nat Genet. 2000; 24(2):192-6. DOI: 10.1038/72869. View

5.
Zimmer S, Stocker A, Sarbolouki M, Spycher S, Sassoon J, Azzi A . A novel human tocopherol-associated protein: cloning, in vitro expression, and characterization. J Biol Chem. 2000; 275(33):25672-80. DOI: 10.1074/jbc.M000851200. View